4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-22-021815
Chief Executive Officer sold 86,877 shares at an average $23.23 ($2,018,344)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirn David Chief Executive Officer | 2022-12-15 | Sale | −31,433 | $23.56 | $740,568 | 1,968,567 | D |
| Kirn David Chief Executive Officer | 2022-12-15 | Sale | −1,500 | $24.13 | $36,199 | 1,967,067 | D |
| Kirn David Chief Executive Officer | 2022-12-16 | Sale | −27,595 | $22.66 | $625,372 | 1,939,472 | D |
| Kirn David Chief Executive Officer | 2022-12-16 | Sale | −26,349 | $23.39 | $616,206 | 1,913,123 | D |
| Open-market sales · 86,877 sh · avg $23.23 · $2,018,344 | |||||||
Loading xslF345X03/doc1.xml…